Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

05/07/03 Parents’ rights at issue        

05/07/03 5K Walk & Family Fun Time at the Fairway Golf Center, 1650 Stelton Rd, Piscataway, NJ. May 31, 2003 - In support of brain tumor research!        

05/07/03 CALGARY, Alberta, May 7, 2003 -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) (‘Oncolytics’) today announced that enrollment has resumed in the Phase I component of its clinical study examining the use of REOLYSIN® in the treatment of recurrent malignant glioma, the most aggressive form of brain cancer.        

05/07/03 Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a new approaches to brain tumor therapy CNS consortium trial.        

05/07/03 Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.        

05/06/03 Cancer patient's courage gives hope - Calgarian pioneered drug trials        

05/06/03 New Approaches for the Treatment of Refractory Meningiomas        

05/05/03 Tectal Gliomas in Children: The Implications for Natural History and Management Strategy        

05/05/03 FDA approves last-chance drug for lung cancer <        

05/01/03 Easing a hospital stay Scout collects DVDs to entertain fellow cancer sufferers        

04/30/03 NeoPharm Announces New Clinical Trial Data for IL13-PE38QQR in Brain Cancer        

04/30/03 Moffitt Center Neuro-Oncology Study of Wafer Implanted During Surgery Shows Zero Tumor Recurrence        

04/29/03 Irinotecan in the treatment of glioma patients.        

04/29/03 The emerging role of irinotecan (CPT-11) in the treatment of malignant glioma in brain tumors.        

04/29/03 Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.        

04/29/03 Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapy.        

04/29/03 Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.        

04/29/03 Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas.        

04/28/03 Brain Tumor Awareness Fair

Huntington Beach, Ca

Sunday May 4th, 2003        

---

Displaying Stories 5890 to 5909 of 7812
Previous 20           Next 20